GleamWall
中文EN

BGMS Bio Green Med Solution, Inc.

Wholesale-Durable Goods, NEC · Nasdaq · SEC CIK 1130166 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY69.4%
TTM EPS YoY75.3%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-156.1%
Net margin-114.5%
FCF margin—
EBITDA margin-155.7%

Returns

ROE-24.2%
ROA-21.3%
ROIC (approx.)-68.7%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets10.9%
Debt / equity0.00x
Current ratio6.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$43,000
R&D expense$848,000$6.66M
SG&A expense$7.72M$5.39M
Operating income-$8.43M-$12.00M
Pretax income-$2.99M-$11.99M
Income tax$7,000-$782,000
Net income-$3.00M-$11.21M
EBITDA-$8.42M-$12.00M
EPS (basic)-6.45-502.46
EPS (diluted)-6.45-502.46
Weighted avg. shares (diluted)2.19M22,314
Banking
Net interest income$62,000$12,000
Balance sheet
Cash & equivalents$3.50M$3.14M
Receivables$1.26M—
Inventory$1.38M—
Current assets$6.26M$3.67M
PP&E, net$137,000$3,000
Goodwill$1.57M—
Total assets$8.19M$4.09M
Current liabilities$1.33M$6.27M
Total liabilities$1.34M$6.27M
Shareholders' equity$6.84M-$2.17M
Shares outstanding5.40M36,913
Cash flow statement
Operating cash flow-$4.77M-$7.99M
Financing cash flow$5.26M$7.82M
Depreciation & amortization$5,000$6,000
Stock-based compensation$2.33M$592,000

Free plan shows the latest 2 periods; Pro shows all 28 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.